ASSOCHAM projects India pharma market at USD 120–130 billion by 2030
Knowledge paper outlines growth drivers, biosimilars opportunity and priorities for India Pharma 2030
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glenmark launches Winlevi for acne vulgaris across European markets
Launch follows European Commission authorisation and expands availability of clascoterone cream for adults and adolescents in…
CDSCO approves Trastuzumab Deruxtecan for first-line HER2-positive breast cancer
Approval expands indication for Trastuzumab Deruxtecan in combination with Pertuzumab for adults with unresectable or metastatic…
Merck India and Oval Fertility sign MoU to expand access to fertility care
Partnership focuses on clinical capability building, patient support, technology integration and data-led approaches to improve…
Beyond ozempic: GLP-1s and the next wave of anti-obesity drugs
Saloni Paliwal, Co-founder, Voy India highlights the evolution of GLP-1 therapies beyond Ozempic, examining the science, market…
Commerce Ministry highlights pharma export growth in Mumbai outreach
Government details 12-year reforms, rising exports, trade partnerships and roadmap for value-led expansion at Pharmexcil event
Hashgraph Group and Merck collaborate to expand Digital Product Passport platform
Collaboration combines TrackTrace and M-Trust technologies to support product traceability, authentication and compliance with EU…
GSK to acquire Nuvalent for $10.6 billion to expand lung cancer portfolio
The deal adds zidesamtinib, neladalkib and NVL-330 to GSK’s oncology pipeline, with two products currently under FDA review for…
Lilly’s orforglipron outperforms oral semaglutide in Phase 3 diabetes trial
Results from the ACHIEVE programme show A1C reduction and weight loss outcomes for orforglipron across three Phase 3 trials
India patent office can bridge the gap with global patent search platforms
The author highlights how India’s patent search ecosystem compares with WIPO, USPTO and Espacenet, and outlines the features…